Dataset Information

Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficits.

ABSTRACT: TMEM106B has been recently implicated in multiple neurodegenerative diseases. Here, Rademakers et al. report a late-onset cerebellar Purkinje cell loss and progressive decline in motor function and gait deficits in a conventional Tmem106b-/- mouse model. By using high-power microscopy and bulk RNA sequencing, the authors further identify lysosomal and immune dysfunction as potential underlying mechanisms of the Purkinje cell loss.

SUBMITTER: Rademakers R

PROVIDER: S-EPMC8412084 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficits.

Rademakers Rosa R Nicholson Alexandra M AM Ren Yingxue Y Koga Shunsuke S Nguyen Hung Phuoc HP Brooks Mieu M Qiao Wenhui W Quicksall Zachary S ZS Matchett Billie B Perkerson Ralph B RB Kurti Aishe A Castanedes-Casey Monica M Phillips Virginia V Librero Ariston L AL Fernandez De Castro Cristhoper H CH Baker Matthew C MC Roemer Shanu F SF Murray Melissa E ME Asmann Yan Y Fryer John D JD Bu Guojun G Dickson Dennis W DW Zhou Xiaolai X Zhou Xiaolai X

Brain pathology (Zurich, Switzerland) 20210311 3

TMEM106B has been recently implicated in multiple neurodegenerative diseases. Here, Rademakers et al. report a late-onset cerebellar Purkinje cell loss and progressive decline in motor function and gait deficits in a conventional Tmem106b-/- mouse model. By using high-power microscopy and bulk RNA sequencing, the authors further identify lysosomal and immune dysfunction as potential underlying mechanisms of the Purkinje cell loss. ...[more]

PMID: 33709463

Similar Datasets

Project description:Genetic variants that define two distinct haplotypes at the TMEM106B locus have been implicated in multiple neurodegenerative diseases and in healthy brain aging. In frontotemporal dementia (FTD), the high expressing TMEM106B risk haplotype was shown to increase susceptibility for FTD with TDP-43 inclusions (FTD-TDP) and to modify disease penetrance in progranulin mutation carriers (FTD-GRN). To further elucidate the biological function of TMEM106B and determine whether lowering TMEM106B may be a viable therapeutic strategy, we performed brain transcriptomic analyses in 8-month-old animals from our recently developed Tmem106b-/- mouse model. We included 10 Tmem106b+/+ (WT), 10 Tmem106b+/- and 10 Tmem106-/- mice. The most differentially expressed genes (153 down-regulated and 60 upregulated) were identified between Tmem106b-/- and WT animals, with an enrichment for genes implicated in myelination-related cellular processes including axon ensheathment and oligodendrocyte differentiation. Co-expression analysis also revealed that the most downregulated group of correlated genes was enriched for myelination-related processes. We further detected a significant loss of Olig2-positive cells in the corpus callosum of Tmem106b-/- mice, which was present already in young animals (21 days) and persisted until old age (23 months), without worsening. qPCR revealed a reduction of differentiated but not undifferentiated oligodendrocytes cellular markers. While no obvious changes in myelin were observed at the ultrastructure levels in unchallenged animals, treatment with cuprizone revealed that Tmem106b-/- mice are more susceptible to cuprizone-induced de-myelination and have a reduced capacity to re-myelinate, a finding which we were able to replicate in a newly generated Tmem106b CRISPR/cas9 knock-out mouse model. Finally, using a TMEM106B HeLa knock-out cell line, we determined that loss of TMEM106B leads to abnormalities in the distribution of lysosomes and PLP1 trafficking but not to differences in MOG trafficking which is lysosome-independent. Together these findings reveal an important function for TMEM106B in myelination with possible consequences for therapeutic strategies aimed at lowering TMEM106B levels.

Dataset Information

Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficits.

Publications

Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficits.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets